I'm a journalist who writes about how biology is shaping our future. Most recently, I was a staff writer at OneZero, Medium's in-house tech and science publication, where I covered CRISPR, genetic privacy, neurotechnology, aging research, the future of fertility, and Covid-19. At OneZero, I broke stories on the first planned pig-to-human organ transplants, the disastrous effects of CRISPR on human embryos, and a dubious $1 million pay-to-play clinical trial to reverse aging. I also wrote deep dives on a DARPA program to make radiation-proof soldiers, the effort to design a universal coronavirus vaccine, and the ethics of using gene therapy to "cure" inherited deafness


Previously, I was the associate editor for biomedicine at MIT Technology Review, where I won a Newsbrief Award from the D.C. Science Writers Association for my story about a menstrual cycle-on-a-chip and was named a finalist for a National Institute for Health Care Management Foundation Journalism Award for my enterprising coverage of a U.S. doctor illegally marketing a "three-person IVF" business.


​My stories have appeared in The Washington Post, New York Times, Wall Street Journal, Scientific American, National Geographic, STAT, The Atlantic and The Baltimore Sun, among others.  


I started my career as a reporter at the Baltimore Business Journal, where I followed the high-profile case of a Maryland cardiologist accused of implanting unnecessary heart stents in patients. I earned my bachelor's degree in journalism at Ohio University and a master's in science writing from Johns Hopkins, where I now teach.